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Peptide antibioticThemultifarious Tat peptide derived from the HIV-1 virus exhibits antimicrobial activity. In this article, we use
Quartz Crystal Microbalance with Dissipation monitoring (QCM-D) to investigate the mechanisms of action of
Tat (44–57) and Tat (49–57) on bacterial-mimetic 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)/
1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (sodium salt) (DMPG)membranes. The results reveal
that both peptides disrupt DMPC/DMPG membranes via a surface-active (carpet-like) mechanism. The
magnitude of this disruption is dependent on both membrane and peptide properties. Firstly, less disruption
was observed on the more negatively charged membranes. Secondly, less disruption was observed for the
longer and slightly more hydrophobic Tat (44–57) peptide. As a comparison, the behaviour of the two Tat
peptides on mammalian-mimetic DMPC/cholesterol membranes was investigated. Consistent with the
literature no membrane disruption was observed. These results suggest that both electrostatic and
hydrophobic interactions, as well as peptide geometry, determine the antimicrobial activity of Tat. This
should guide the development of more potent Tat antibiotics.61 3 99054597.
n).
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The increasing number of antibiotic-resistant bacteria and the
decreasing number of new antibiotics in development are leading to a
public health crisis [1,2]. Antimicrobial peptides (AMPs) are a
promising solution because they are generally selective for bacterial
membranes; they have broad-spectrum antibacterial activity and
some show antifungal, antiviral and anticancer activity; and the
development of bacterial resistance to AMPs is difﬁcult [3–8]. AMPs
are also a realistic solution with, for example, MSI-78 (Pexiganan)
reaching phase III clinical trials for topical treatment of diabetic foot
ulcers (although FDA approval was later denied) [9]. Recently, it was
demonstrated by Jung and co-workers that the HIV-1 virus nuclear
transcription activating protein Tat (residues 47–58) exhibits anti-
fungal and antibacterial activity [10,11]. Importantly, Tat (47–58)
exerted toxic activity towards all multi-drug resistant Staphylococcus
aureus and Pseudomonas aeruginosa strains tested (with minimum
inhibitory concentrations (MICs) of 0.625–20 μM), had no hemolytic
activity over that range, and the D-enantiomer was resistant to
proteolytic degradation, making it a potential therapeutic agent [11].
In contrast to the hotly debated mechanism of action of Tat on
eukaryotic cells [12–14], there are relatively few studies concerninghow Tat exerts its antibacterial activity. The current view is that,
ﬁrstly, on addition of Tat to bacterial-mimetic liposomes consisting of
phosphocholine (PC) and phosphoglycerol (PG) lipids, Tat binds with
high afﬁnity and remains unstructured on the membrane surface
[15,16]. The binding of the positively charged Tat to the negatively
charged PC/PG membrane results in charge neutralisation, which
facilitates liposome aggregation [17]. Fusion was then observed for
the unsaturated dioleoyl (DO) liposomes, which suggests that binding
causes membrane destabilisation [17]. However, any Tat-induced
membrane destabilisation is small, as ﬂuorescent dye leakage
experiments showed that only b10% of the entrapped dye was
released from the PC/PG liposomes [15,17]. Furthermore, Tat caused
negligible membrane depolarisation of Staphylococcus aureus cells
[18]. These results suggest that Tat does not act via a pore or carpet
mechanism [19]. Instead, it is thought that Tat translocates through
bacterial membranes and acts on an intracellular target [18], as
observed for its antifungal activity [10] and for other AMPs [20,21].
While Tat is non-disruptive, dimerisation of the peptide at the C-
terminus confers a membrane-disruptive mode of action [18].
Quartz CrystalMicrobalancewith Dissipationmonitoring (QCM-D)
has been employed by us and others to investigate the mode of action
of AMPs [20–26]. A biomimetic lipidmembrane can be deposited onto
the QCM-D sensor ‘chips’ in situ [27]. Upon addition of an AMP
solution, themass and structural changes to the lipidmembrane canbe
monitored in real time by the QCM-D instrument. QCM-D can
therefore provide direct information about the effect of the AMP on
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this study, QCM-D is used to investigate the behaviour of Tat (44–57)
(Ac-GISYGRKKRRQRRR-NH2, basic residues are underlined) and Tat
(49–57) (Ac-RKKRRQRRR-NH2) on bacterial-mimetic membranes
and, as a comparison, mammalian-mimetic membranes. Consistent
with the reported non-lytic activity of Tat on eukaryotic cells, we show
that both Tat peptides add to the membrane with no loss of mass.
However, in contrast to the current literature, Tat is shown to disrupt
bacterial membranes via a surface-active mechanism. Reasons for this
discrepancy are considered.
2. Materials and methods
2.1. Peptide synthesis
Tat (44–57) and Tat (49–57) with N-terminal acetylation and C-
terminal amidation were synthesised with L-amino acids by auto-
mated solid phase peptide synthesis on a Rink amide resin.
2.2. Buffer preparation
Sodium chloride (≥99.5%), potassium phosphate monobasic
(anhydrous, ≥99.0%) and potassium phosphate dibasic (anhydrous,
≥98%) were purchased from Sigma-Aldrich (Castle Hill, Australia).
Ultrapure water was used with an initial resistivity of 18.2 MΩ·cm
(Sartorius AG, Göttingen, Germany). Phosphate buffered saline (PBS,
pH 6.9±0.1) was prepared having 20 mM phosphate and either
100 mM (“high-salt”) or 30 mM (“low-salt”) sodium chloride in
water.
2.3. Liposome preparation
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-
dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (sodium salt)
(DMPG) were purchased from Avanti Polar Lipids (Alabaster, USA).
Cholesterol, chloroform (≥99.8%) and methanol (≥99.9%) were
purchased from Sigma-Aldrich (Castle Hill, Australia). DMPC and
cholesterol were dissolved in chloroform and DMPG was dissolved in
chloroform/methanol (ca. 3:1) to create individual 5 mM stock
solutions. These solutions were then aliquoted into test tubes to
obtain the desired lipid composition (DMPC/cholesterol 7:3 v/v, and
DMPC/DMPG 4:1 and 2:1 v/v). The solvent was evaporated under N2
and the test tubes were then dried under vacuum. To prepare the
liposomes, the lipids were resuspended in high-salt PBS (100 mM
NaCl) to a lipid concentration of 0.5 mM and then incubated at 37 °C,
vortexed and brieﬂy sonicated (b5 min) in a bath sonicator before
use. The resultant liposomes are unilamellar and have a bimodal size
distribution, with the radii of the two populations on average ca. 50
and 300 nm [28].
2.4. Modiﬁcation of QCM-D sensor chips
Absolute ethanol (≥99.7%), propan-2-ol (≥99.0%) and hydrogen
peroxide (30%) were purchased from Merck (Kilsyth, Australia).
Ammonium hydroxide solution (28%) was obtained from Ajax
Finechem (Seven Hills, Australia). 3-Mercaptopropionic acid (MPA,
≥99.0%) was purchased from Fluka, BioChimica (Buchs, Switzerland).
The QCM-D sensor crystals used were polished, gold-coated, AT-cut
quartz chips with a fundamental frequency of ca. 5 MHz (Q-Sense,
Västra Frölunda, Sweden). Immediately before measurements the
chips were cleaned in a solution of ammonium hydroxide: hydrogen
peroxide: water (1:1:3 v/v) for 20–25min at ca. 70 °C. The chips were
then rinsed thoroughly with water. Surface modiﬁcation with MPA
was conducted by immersing a freshly cleaned chip into a 1 mM
solution of MPA in propan-2-ol for at least 1 h. This creates a self-
assembled monolayer of negative charge on the chip surface. ExcessMPA was removed by rinsing with propan-2-ol. The chips were then
dried under N2 and assembled into the QCM-D chambers ready for
use.
2.5. QCM-D experiments
QCM-D experiments were performed using the E4 system with
ﬂow cells (Q-Sense, Västra Frölunda, Sweden). The QCM-D instrument
measures the relative changes to the resonance frequency (f) and
energy dissipation (D) of the chip over the course of the experiment.Δf
and ΔD were measured simultaneously at the fundamental frequency
and the 3rd, 5th, 7th and 9th harmonics. All plots presented in this
study will use the 7th harmonic unless otherwise stated. Data for the
fundamental frequency is not presented as it is inherently noisy and
unreliable. The original datawas processed in QTools (Q-Sense) before
being exported for further analysis in OriginPro 8 (OriginLab Corp.,
Northampton, USA). All experimentswere conducted at a temperature
of 19.10±0.05 °C and repeated at least three times.
In a typical experiment, ﬁrstly, a lipid membrane was formed on
the chip surface by the introduction of a liposome solution into the
QCM-D chamber at a ﬂow rate of 50–100 μL/min. The liposomes
adsorb onto the MPA-monolayer, deform, rupture and fuse together
to form a lipid bilayer [28]. Weakly attached liposomes were removed
by washing with high-salt PBS (100 mM NaCl) at 300 μL/min and any
embedded liposomes were ruptured by washing with low-salt PBS
(30 mM NaCl) at 300 μL/min. This second washing step was
introduced to ensure the formation of a homogeneous membrane
and works by creating an osmotic pressure difference between the
interior of the embedded liposomes (having a high salt concentration)
and the low-salt exterior environment, which causes the liposomes to
swell and then burst. Secondly, after a stable baseline was observed,
1 mL of peptide solution (1, 2, 5, 10 and 15 μM in PBS) was introduced
at 50 μL/min. After the ﬂow was stopped, the peptide was left to
incubate with the lipid membrane for 30 min and then the chamber
was rinsed with high-salt PBS.
The change in mass of the chip (Δm) can be calculated using the
Sauerbrey equation [29]:
Δm = −C Δfn
n
 
ð1Þ
where C is the mass sensitivity constant (17.7 ng/cm2·Hz for a chip
with a fundamental frequency of 5 MHz) and n is the harmonic
number. All mass values reported use the 7th harmonic (n=7) unless
otherwise stated. Cho and co-workers have demonstrated that the
Sauerbrey equation effectively models lipid bilayers in aqueous buffer
[30].
3. Results and discussion
3.1. QCM-D results for Tat interaction with mammalian membranes
The behaviour of Tat (44–57) and Tat (49–57) on mammalian-
mimetic membranes is presented here as a comparison since, despite
being the subject of intense debate, it is accepted that Tat does not
disrupt mammalian cells (Tat penetration is thought to proceed via
one or all of endocytosis, pore formation, inverted micelle formation
and/or direct translocation [12,31,32]). A lipid combination of DMPC/
cholesterol was used, as phosphocholine and cholesterol are the
major constituents of mammalian membranes [33]. The model
systems were kept as simple as possible to focus on the peptide–
phospholipid interaction.
In a QCM-D instrument, an alternating-current (AC) voltage is
applied across a quartz chip to cause the chip to oscillate in shearmode
at its fundamental frequency (f0) and harmonics of the fundamental
frequency (fn, where n is the harmonic number). The driving AC
Fig. 2. Δf–t (A) and ΔD–t (B) plots obtained for the interaction of Tat (44–57) with a
DMPC/cholesterol membrane. The response of four peptide concentrations is shown (1,
5, 10 and 15 μM; lightest to darkest lines). Time points (v) and (vi) correspond to
peptide addition and buffer rinse, respectively.
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into the surrounding environment, giving the dissipation factor (D)
[34]. The results from a typical QCM-D experiment are shown in Fig. 1.
The Δf–time plot in panel A shows changes in mass over the course of
the experiment; a decrease in Δf corresponds to an increase in mass
density (see Equation (1) and ref. [29]). The ΔD–time plot in panel B
shows changes in structure; an increase inΔDmeans the chip dissipates
its energy more quickly when the driving AC voltage is removed and
suggests the ﬁlm on the chip is thicker, softer or more loose [34,35].
The experiment in Fig. 1 commenced with the chip oscillating in high-
salt PBS and at point (i) the liposome solution was introduced into the
QCM-D chamber. This causes an increase in mass of the chip, as
liposomes adsorb, deform, rupture and fuse to form a lipidmembrane.
Flow was stopped after a change in Δf of ca. −15 Hz, which
corresponds to one complete bilayer (as explained in ref. [28]). A
high-salt PBS rinse was performed at point (ii) to remove unadsorbed
liposomes from the chamber. The decrease in mass resulting from the
removal of weakly bound liposomes is offset by an increase in mass
caused by residual liposomes from the tubing entering the QCM-D
chamber and adsorbing and rupturing on the chip surface. At point
(iii) the chamber was rinsed with low-salt PBS, which causes a rapid
increase in Δf and decrease in ΔD. This is because of, ﬁrstly, the
sensitivity of the resonance frequency and energy dissipation of the
chip to the density and viscosity of the surrounding solution [36] and,
secondly, the rupturing of embedded liposomes due to osmotic
pressure difference. This rupturing expels water trapped inside the
liposomes, causing the decrease in mass observed, and increases the
rigidity of the membrane, resulting in the lower energy dissipation.
The chamber was ﬂushed with high-salt PBS at point (iv) until a
baseline was established, whereupon the peptide solution was
introduced at point (v). After allowing the peptide and membrane to
incubate for 30 min, the chamber was washed with high-salt PBS at
point (vi), concluding the experiment.3.1.1. Tat (44–57) on DMPC/cholesterol
First we investigated the interaction of Tat with DMPC/cholesterol
membranes over a concentration range of 1–15 μM, which corre-
sponds to the MIC range for Tat on bacterial cells [11,18]. The results
are presented in Fig. 2. On introduction of Tat (44–57) into the QCM-D
chamber there was a small decrease in Δf, which corresponds to anFig. 1. Results for a typical QCM-D experiment. Δf–t (A) and ΔD–t (B) plots are
presented. At time point (i) a liposome solution was introduced into the chamber; at
points (ii), (iv) and (vi) the chamber was ﬂushed with high-salt PBS; at point (iii) the
chamber was ﬂushed with low-salt PBS; and at point (v) the peptide solution was
introduced into the chamber. See text for further explanation.increase in mass of the chip. This mass addition caused negligible
change in ΔD (b0.5 × 10−6), suggesting that there is no change in the
membrane structure. Similar results were observed for Tat (49–57)
(data not shown).
Several conclusions can be drawn from Fig. 2. Firstly, as expected
and consistent with the literature, Tat does not disrupt mammalian
membranes; a one-step mass addition process was observed at all
concentrations. Secondly, Tat addition only proceeds until membrane
saturation is reached. That is, while the rate of Tat addition was
dependent on the concentration of peptide in solution, the overall
amount of peptide added was independent; a change in Δf of−4.0±
0.3 Hz (Δm=57±4 ng) was observed for all concentrations. Thirdly,
the buffer wash performed after incubation (point (vi) in Fig. 2)
removes a negligible amount of material from the surface (b5%),
which suggests that binding is irreversible. We have previously
studied knownmembrane-penetrating AMPs e.g. apidaecin 1a and 1b
and oncocin (peptide 10). They show a similar QCM-D response to Tat,
i.e. peptide addition with no change in energy dissipation, however,
on washing with buffer N50% of the bound peptide is removed
[20,21,24]. Thus the strong afﬁnity between Tat and the membrane is
unique compared with some other cell-penetrating peptides that we
have studied using QCM-D.
These conclusions are consistent with three possible mechanisms.
The ﬁrst mechanism involves strong Tat binding to the phosphate
residues of themembrane. Shawand co-workers observed using atomic
force microscopy that bilayer association of Tat was phase-dependent,
causing anapparentheight increaseof liquid-phasedomains (either due
to peptide aggregation on ormembrane restructuring of these domains)
[37]. At the cholesterol concentration of 30 mol% used in our experi-
ments only the liquid-ordered phasewould be present [38,39]. Thus the
small increase in ΔD upon peptide addition could be explained by the
height increase observed by Shaw et al. However, according to Shaw et
al. there should be a difference between Tat interaction with gel-phase
DMPC and liquid-ordered phase DMPC/cholesterol membranes. We
observed negligible difference between the two membranes (data not
shown), suggesting either that Tat association is not always phase-
dependent or our experimental conditions are promoting a different
mechanism of action. Furthermore, Dennison and co-workers demon-
strated that Tat (48–60) binds weakly to DMPC monolayers, due to its
low hydrophobicity [40]. This ﬁrst mechanism would therefore be
unlikely according to their study, as we observed an irreversible and
strong association to the membrane.
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pore formation, which has been observed experimentally and
demonstrated in silico [41–45]. We have previously postulated that
if the change in resonance frequency is similar for all harmonics in an
experiment, this is an indication that the peptide has inserted into the
membrane in a transmembrane manner [22]. This is because the
depth probed by a harmonic is inversely proportional to its frequency
[46]; higher harmonics probe close to the surface of the chip and
lower harmonics probe further away from the surface. If all harmonics
measure the same change in frequency, this means that mass density
is the same across the whole thickness of the membrane (i.e. pore
formation). This is observed for Tat addition to DMPC/cholesterol
(data not shown).
The third mechanism is direct translocation through the mem-
brane. Tat penetration has been observed in the absence of en-
docytosis or pore formation, hinting to the existence of a currently
unspeciﬁed direct translocation mechanism [31,47]. In our experi-
ments the membrane is supported by a negatively charged carboxylic
acid-terminated monolayer. It is possible that the highly positively
charged Tat penetrates through themembrane and binds to this MPA-
monolayer. This would weaken the interaction between the sensor
chip and themembrane, resulting in the increase in energy dissipation
observed.
Therefore, the QCM-D results are consistent with three alternative
mechanisms that cannot be distinguished using this data alone. We
are currently employing complementary techniques to further clarify
the mechanism of action. However, the interaction of Tat with DMPC/
cholesterol provides an experiment from which we can compare the
behaviour of Tat on bacterial-mimetic membranes.
3.2. QCM results for Tat interaction with bacterial membranes
3.2.1. Tat (49–57) on DMPC/DMPG 4:1
A DMPC/DMPG (4:1) membrane is used as the model system for
prokaryotic membranes, as the inclusion of DMPG mimics the
negatively charged components found on the surface of bacteria
[48]. The behaviour of Tat (49–57) on this membrane is shown in
Fig. 3. It is important to point out that Fig. 3 presents one peptide
concentration and the response of four different harmonics (cf. Fig. 2).
The results show that interaction between Tat (49–57) and DMPC/
DMPG (4:1) occurs via a biphasic mechanism: peptide addition
followed bymembrane disruption. On introduction of the peptide intoFig. 3. Δf–t (A) and ΔD–t (B) plots obtained for the interaction of a 10 μM solution of Tat
(49–57) with a DMPC/DMPG 4:1 membrane. The response of four harmonics is shown
(3rd, 5th, 7th and 9th harmonics; darkest to lightest lines). Time points (v) and (vi)
correspond to peptide addition and buffer rinse, respectively.the QCM-D chamber, there was a decrease in frequency of ca. 4 Hz at
all harmonics. This value was consistent across all experiments
(Δfav=−3.8±0.7 Hz). After membrane saturation was reached, mass
was removed from the chip surface in a harmonic-dependent manner.
That is, the greatest mass loss was observed at the 3rd and 5th
harmonics, which probe further from the chip surface, while less mass
loss was observed at the chip surface-sensing 7th and 9th harmonics
(Fig. 3A). Therefore, disruption occurs on the surface of the
membrane; consistent with a “carpet mechanism” [19,22,24]. The
loss of mass was accompanied by a decrease in ΔD (Fig. 3B). This is
because energy dissipation is proportional to thickness, according to
the Kelvin–Voigt model of viscoelasticity. Furthermore, highly
dissipating bilayer patches sitting on top of the complete bilayer
may have been removed, contributing to the decrease in ΔD. The
buffer rinse performed at the end of the experiment (point (vi) in
Fig. 3) resulted in a negligible change in mass.
Disruption of PC/PGmembranes has not been previously observed.
Thorén and co-workers reported that TatP59W(Ac-GRKKRRQRRRPWQ-
NH2) caused the leakage of only 1.9% of entrapped carboxyﬂuorescein
from DOPC/DOPG (3:2) vesicles [17]. Zhu and Shin reported that Tat
(48–60; GRKKRRQRRRPPQ) induced the release of ca. 10% of entrapped
calcein from egg yolk phosphoethanolamine/PG (7:3) vesicles [18].
Under the same conditions, TatP59Wcaused the leakage of ca. 20% of the
ﬂuorescent dye [18], in contrast to the 1.9% determined by Thorén et al.
Ruzza and co-workers observed that Tat (48–61; GRKKRRQRRRPPQG)
caused the leakage of ca. 10% of calcein fromDMPC/DMPG (3:1) vesicles
[15]. Finally, Yangandco-workers reported that Tat (48–61;GRKKRRQR-
RRPPQC) caused b5% leakage of ANTS/DPX dye from DOPC/DOPG (1:1)
vesicles [49]. Therefore, experimental differences could explain the
discrepancy between the results of this study and earlier work. Firstly,
higher peptide concentrations were used in our study (1–15 μM) and
signiﬁcant loss of mass from the membrane was only observed at
concentrations above 5 μM. This concentration range is lower than the
MIC values of Tat of 0.6–20 μM as determined by Jung et al. [11].
Secondly, Tat (44–57) and Tat (49–57) peptides were studied here and
differences in sequence will change membrane activity (see below).
Thirdly, the aforementioned studies were conducted on bilayers in the
liquid-phase, whereas in our study the bilayers were in the gel-phase.
Membrane defects tend to exist in bilayers formed below their phase-
transition temperature and it is possible that these defects make the
membrane more susceptible to disruption [50]. Finally, the dye-leakage
studies summarised above used small (≤100 nm) vesicles, which
exhibit high shear moduli, lower deformation, and hence are less likely
to undergo disruption comparedwith planar bilayers [28,51]. The results
of this study are, therefore, not inconsistent with the existing literature
but instead outline a set of prerequisite factors for observable bacterial
membrane disruption by the Tat peptide.
3.2.2. Effect of hydrophobicity of Tat and negative charge of membrane
The effect of peptide hydrophobicity on bacterial membrane
disruption was investigated by using the longer-sequence peptide
Tat (44–57). Both Tat (49–57) and Tat (44–57) have a net charge of
+9 at pH 7.4. However, the free energy of transfer from water to lipid
interface for Tat (44–57) is 3.77 kcal/mol and for Tat (49–57) it is
4.87 kcal/mol, according to the Wimley and White (WW) scale
[52,53]. That is, Tat (44–57) is more hydrophobic than Tat (49–57).
The effect of membrane charge was investigated by increasing the
percentage of DMPG in the membrane from 20% to 33%. The results
are presented as plots of Δf versus ΔD in Fig. 4 (called “Δf–ΔD plots”).
A comprehensive explanation of the interpretation of Δf–ΔD plots can
be found in ref. [24]. In summary, these plots illustrate how the
structure of the lipid membrane changes per unit mass addition [35].
Each discrete point in the plot represents the value of Δf and ΔD at a
certain time. In Fig. 4, the point (0,0) corresponds to the time when
the peptide solution was introduced into the QCM-D chamber. The
last point in each trace corresponds to the end of the incubation
Fig. 4. Representative Δf–ΔD plots for the interaction of a 10 μM solution of either Tat
(49–57) or Tat (44–57) on a DMPC/DMPG 2:1 or 4:1membrane. The x-axis is Δf and the
y-axis is ΔD. The coordinate (0,0) corresponds to the time when the peptide solution
was introduced into the QCM-D chamber. Time increases along the trace and the last
point in the trace corresponds to the end of the incubation period (i.e. the time window
from points (v) to (vi) is shown; see Fig. 1). The response of the 3rd, 5th, 7th and 9th
harmonics is presented (darkest to lightest dots).
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(see Fig. 1).
For example, for Tat (49–57) on DMPC/DMPG 4:1 in Fig. 4 (top-
right panel) the Δf–ΔD plot has one turning point at Δf≈−3 Hz and
ΔD≈0. Therefore, it interacts with the membrane via a two-phase
mechanism [24]. The ﬁrst phase can be described by an arrow
beginning at (0,0) and ending at the turning point at (−3,0). Using
Fig. 5 as a guide, it can be seen that this due east arrow corresponds to
mass addition with no change in membrane structure. The second
phase can be described by an arrow beginning at the turning point at
(−3,0) and ending at the last point in the trace (e.g. point (0,−6) for
the 9th harmonic). This is a south-west arrow, which corresponds to
mass loss and increase in rigidity of the membrane. This south-west
arrow extends into +Δf values, which indicates a net loss of mass
from the surface and not merely a desorption of peptide. Therefore,
either using the Δf–t and ΔD–t plots or one Δf–ΔD plot, the same
conclusion that Tat interacts with bacterial membranes according to a
biphasic mechanism is reached.Δf–ΔD plots are used in this section of
the article because they enable easy comparison between different
QCM-D experiments (see Fig. 4).Fig. 5. Interpretative guide for Δf–ΔD plots. This guide was ﬁrst introduced by us in ref.
[24] to assist in the interpretation of Δf–ΔD plots.For both Tat peptides, less membrane disruption was observed on
the more negatively charged DMPC/DMPG (2:1) membranes (Fig. 4).
This seems counter-intuitive; prima facie, more peptide would be
expected to bind to the more negatively charged membrane in order
to achieve charge neutralisation, inducing greater stress in the
membrane and causing larger disruption. Indeed, more peptide was
observed to bind to the DMPC/DMPG (2:1) membranes (e.g. for Tat
(49–57), Δfav=−5.8±1.3 for 2:1 membrane versus Δfav=−3.7±
1.3 for 4:1 membrane, at the 3rd harmonic). Thus increasing the
negative charge on the membrane increases the amount of Tat that
adsorbs. However, this increased adsorption does not lead to
increased disruption. The reason for reduced disruption on DMPC/
DMPG (2:1) must be due to how the Tat peptides interact with the
surface. It was demonstrated by Ruzza and co-workers that Tat (48–
61) shows a lower afﬁnity towards neat DMPG liposomes than DMPC/
DMPG (3:1) liposomes [15]. Similarly, various oligoarginines (R6, R8
and R10) all exhibited lower afﬁnity towards the more negatively
charged DMPG liposomes [15]. This suggests that both electrostatic and
hydrophobic interactions dictate binding strength [15,54]. Increasing
the negative charge of the membrane may increase electrostatic
attraction, but binding strength is lowered overall because ofweakened
hydrophobic interactions. Lower afﬁnity means less stress is placed on
the membrane and, therefore, less disruption is observed on DMPC/
DMPG (2:1) membranes compared with DMPC/DMPG (4:1)
membranes.
On both membranes, less disruption was observed for the more
hydrophobic Tat (44–57) peptide (Fig. 4). This result seems
inconsistent with the analysis above. Indeed, Zhu and Shin reported
that the more hydrophobic TatP59W had smaller MIC values and
induced more dye leakage in bacterial-mimetic liposomes than the
native Tat peptide [18]. Furthermore, Thorén and co-workers
hypothesised that this tryptophan substitution would reorientate
the amidated C-terminus of the peptide deeper into the membrane,
creating defects in lipid packing that should enhance membrane
destabilisation [17]. However, in Tat (44–57) the hydrophobic
residues Ile45 and Tyr47 are separated by hydrophilic Ser46 and are
located near the hydrophilic acetylated N-terminus. Therefore, it is
unlikely that the N-terminus would protrude into the membrane
interior as Thorén et al. suggested for their peptides. Similarly, Zhu
and Shin were comparing Tat (48–60), with a WW free energy of
8.64 kcal/mol, with amidated TatP59W, which has a WW free energy
of 4.44 kcal/mol. Therefore, the difference in liposome dye leakage
between the two peptides is explained by the drastic difference in
hydrophobicity (95% variation in free energy values). In our study,
this difference is much less (30%). Because the difference in
hydrophobicity between Tat (44–47) and Tat (49–57) is relatively
small it is possible that other differences between the two peptides
dominate. For example, length may be a determining factor. The
shorter Tat (49–57) peptide may enable closer packing, resulting in a
greater membrane strain over a smaller area, which would enhance
membrane disruption. Several groups have reported that increasing
peptide length increases antimicrobial activity [55,56]. However,
these studies investigated the effect of length by varying the number
of repeat units e.g. (RW)n-NH2 (where n=1–5) [56]. This means the
interaction between peptide and membrane will be consistent over
the length of the peptide. In our study, the longer Tat (44–57) is not
necessary more active, because the 44GISYG48 unit may have no
activity. Therefore, the slight increase in hydrophobicity, the inability
of the N-terminus to protrude into the membrane and the longer
length of Tat (44–57) may explain why it exhibits less disruptive
activity compared with Tat (49–57).
4. Conclusion
In this study, we determined that two truncated Tat sequences, Tat
(44–57) and Tat (49–57), exert their antimicrobial activity via the
1816 S. Piantavigna et al. / Biochimica et Biophysica Acta 1808 (2011) 1811–1817carpet-like mechanism on planar, gel-phase DMPC/DMPG lipid
membranes. This surface-active mechanism occurs in two stages,
both observable in the QCM-D data. Firstly, the Tat peptides bind to
the membrane surface. The adsorption amount is proportional to the
negative charge of the membrane; the higher the negative charge, the
greater the amount of peptide that adsorbs to achieve charge
neutralisation. Secondly, after a threshold surface coverage is reached,
the peptides disintegrate the membrane by disrupting the membrane
structure [3]. Both electrostatic and hydrophobic interactions deter-
mine the peptide-lipid binding strength and, thus, the magnitude of
membrane disruption. For example, even though more peptide
adsorbed onto the more negatively charged DMPC/DMPG (2:1)
membranes, less disruption was observed due to weakened hydro-
phobic interactions. Furthermore, the length of the peptide may be
important. It was observed that Tat (44–57) was less active than the
shorter Tat (49–57). The shorter peptide may induce a greater
membrane strain per unit area, increasing disruption. Finally, as a
comparison it was determined that neither Tat sequence disrupted
the mammalian-mimetic DMPC/cholesterol membranes, consistent
with the reports that Tat exerts no hemolytic activity [10,11,18]. Our
results suggest that Tat does not simply act through an intracellular
mechanism but also acts on the bacterial membrane, making it a
promising antibiotic for further development [7].
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